Waltham, 2116, MA,
United States
Aerovate Therapeutics, Inc. Technographics
Aerovate Therapeutics, Inc. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Aerovate Therapeutics, Inc. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 18 Aerovate Therapeutics, Inc. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Aerovate Therapeutics, Inc. has purchased the following applications: DocuSign eSignature for Digital Signing in 2023, Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2021, Mimecast Email Security for Secure Email Gateways (SEGs) in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Aerovate Therapeutics, Inc. is running and its propensity to invest more and deepen its relationship with Docusign , Microsoft , Google or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Aerovate Therapeutics, Inc. revenues, which have grown to $2.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Aerovate Therapeutics, Inc. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Aerovate Therapeutics, Inc. Tech Stack and Enterprise Applications
Aerovate Therapeutics, Inc. Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Docusign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2023 | 2023 |
In 2023, Aerovate Therapeutics, Inc. implemented DocuSign eSignature as a Digital Signing solution. The company embedded DocuSign eSignature on its public website to provide an in-place electronic signature experience for external users, enabling web-based signature capture and a verifiable audit trail tied to executed documents.
The deployment uses an embedded web signing architecture and centers on DocuSign eSignature envelope templates, recipient routing, and signature field configuration to support online document workflows. Operational coverage is focused on the customer-facing corporate site, and governance activity is oriented around template management, signer authentication settings, and audit logging consistent with DocuSign eSignature capabilities.
|
Aerovate Therapeutics, Inc. IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft Azure Cloud Services | Application Hosting and Computing Services | IaaS | n/a | 2021 | 2021 |
In 2021, Aerovate Therapeutics, Inc. deployed Microsoft Azure Cloud Services to provide Application Hosting and Computing Services for its public website and external digital presence. Aerovate Therapeutics, Inc. Microsoft Azure Cloud Services Application Hosting and Computing Services supports the company website and marketing communications by hosting web applications, assets, and site content in the cloud.
The implementation concentrates on cloud hosted web application runtimes, virtualized compute and object storage for media and documents, DNS and content delivery capabilities, and role based access controls for administrative governance. Operational coverage is oriented to marketing and communications for the live site, with IT responsible for subscription management and access governance. The architecture follows standard Application Hosting and Computing Services patterns using cloud compute, storage, networking, and identity controls to manage the web estate and associated assets.
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2022 | 2022 |
|
Aerovate Therapeutics, Inc. CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Mimecast | Legacy | Mimecast Email Security | Secure Email Gateways (SEGs) | CyberSecurity | n/a | 2021 | 2021 |
In 2021, Aerovate Therapeutics, Inc. deployed Mimecast Email Security, a Secure Email Gateways (SEGs) solution, to protect email services tied to its corporate domain and public website. The company is a small life sciences organization with approximately 18 employees, and Mimecast Email Security is used to secure inbound and outbound mail streams associated with aerovatetx.com.
Mimecast Email Security was configured to provide core Secure Email Gateways (SEGs) capabilities including inbound and outbound filtering, anti-spam and anti-phishing controls, URL and attachment inspection, policy-based message handling, and centralized quarantine and reporting. The implementation leverages Mimecast’s administrative console for policy creation, user management, and security event monitoring, with standard SEG functional terminology applied to convey mail hygiene, threat protection, and message continuity.
Deployment follows a cloud-delivered gateway architecture, with email routing and domain-level protections applied to the company domain and website-related communication channels. Standard DNS and MX record configuration and email authentication controls such as DMARC, DKIM, and SPF are part of the operational rollout to ensure mail flow is directed through Mimecast Email Security and to enforce sender authentication for the aerovatetx.com domain.
Operational ownership resides with IT and security functions, focusing governance on policy lifecycle, quarantine review workflows, and security incident handling for phishing and malware events. User-facing workflows include quarantine notifications and administrative workflows for message release and exception handling, aligning day-to-day operations with the Mimecast Email Security management console.
|
IT Decision Makers and Key Stakeholders at Aerovate Therapeutics, Inc.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Aerovate Therapeutics, Inc. Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||